UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in CORT — Corcept Therapeutics Inc
CIK 861177
NEW YORK, NY
Position in CORT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,628,499
+$8,862,368 QoQ
Shares Held
202,743
-6.8% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. CORT ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in CORT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,628,499 | 202,743 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,766,131 | 217,468 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,137,546 | 205,102 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $16,848,801 | 202,729 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,267,137 | 330,615 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $25,238,390 | 220,963 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $11,323,284 | 224,713 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,364,848 | 202,352 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,165,048 | 220,531 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,060,583 | 121,500 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,059,998 | 125,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,291,444 | 120,787 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,967,058 | 133,351 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,888,381 | 133,351 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,638,347 | 129,904 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,409,118 | 132,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,898,682 | 163,948 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,788,154 | 168,213 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,962,038 | 149,598 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,914,369 | 148,088 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,032,370 | 137,835 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,154,432 | 132,595 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,722,173 | 142,285 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,901,535 | 109,221 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,852,754 | 110,152 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,256,224 | 105,654 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||